DOI: http://dx.doi.org/10.18203/2349-3933.ijam20212821

Assessment of platelets in patients with pulmonary hypertension

Govardhini Vaiyakkani, Sridhar Sundaravadanam, Gokulakrishnan Harikrishnan, Priyatharicini Anandasekar

Abstract


Background: Pulmonary hypertension (PH) occurs due to end result of multifactorial etiology causing significant morbidity and mortality. Platelets are observed to be activated during initiation and progression of disease, platelets indices used as surrogate markers for platelet activation was used in current study to investigate effect of PH on platelets and correlate it with severity of PH.

Methods: 104 patients with PH were grouped according to WHO classification depending upon etiology. Blood samples of patients from all groups were collected and investigated for platelet indices, peripheral smear, bleeding time, clotting time and echocardiography assessment to know the severity of pulmonary hypertension. Patients were reviewed after 2 months of appropriate treatment.

Results: Prevalence of PH due to chronic lung disease (48.1%) was the most common observation. Thrombocyte count was decreased significantly in all groups of PH with p<0.01. MPV, PDW, P-LCR (platelet-large cell ratio) were observed to be increased with increasing severity for PH. Significant correlation p=0.01 indicated that platelet indices were altered with treatment for PH.

Conclusions: Significant reduction was observed in platelet count with increase in platelet indices can be correlated with severity of PH. Hence in rural areas without echo cardiogram facilities, platelet indices can be considered as surrogate markers for early referral of patients to higher centers for further management of PH.


Keywords


Pulmonary hypertension, Platelet indices, Platelet count

Full Text:

PDF

References


Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):180-9.

Yaghi S, Novikov A, Trandafirescu T. Clinical update on pulmonary hypertension. J Investig Med. 2020;68(4):821-7.

Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary Hypertension. Dtsch Arztebl Int. 2017;114(5):73-84.

Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306-22.

Prins KW, Thenappan T. World health organization group 1 pulmonary hypertension: epidemiology and pathophysiology. Cardiol Clin. 2016;34(3):363-74.

Örem C. Epidemiology of pulmonary hypertension in the elderly. J Geriatr Cardiol. 2017;14(1):11-6.

Ryan JJ, Thenappan T, Luo N, Ha T, Patel AR, Rich S, et al. The WHO classification of pulmonary hypertension: a case-based imaging compendium. Pulm Circ. 2012;2(1):107-21.

Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1):43-54.

Sahay S. Evaluation and classification of pulmonary arterial hypertension. J Thorac Dis. 2019;11(14):1789-99.

Lan NSH, Massam BD, Kulkarni SS, Lang CC. Pulmonary arterial hypertension: pathophysiology and treatment. Diseases. 2018;6(2):38.

Patel R, Aronow WS, Patel L, Gandhi K, Desai H, Kaul D, et al. Treatment of pulmonary hypertension. Med Sci Monit. 2012;18(4):31-9.

Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician. 2001;63(9):1789-98.

Kondo T, Okumura N, Adachi S, Murohara T. Pulmonary hypertension: diagnosis, management, and treatment. Nagoya J Med Sci. 2019;81(1):19-30.

Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1):180-5.

Hambly N, Alawfi F, Mehta S. Pulmonary hypertension: diagnostic approach and optimal management. CMAJ. 2016;188(11):804-12.

McGoon MD, Kane GC. Pulmonary hypertension: diagnosis and management. Mayo Clin Proc. 2009;84(2):191-207.

Goldberg AB, Mazur W, Kalra DK. Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies. Cardiovasc Diagn Ther. 2017;7(4):405-17.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol (Engl Ed). 2016;69(2):177.

Bossone E, D’Andrea A, D’Alto M. Echocardiography in pulmonary arterial hypertension: an essential tool. Chest. 2007;131(2):339-41.

Maron BA, Loscalzo J. Pulmonary hypertension: pathophysiology and signaling pathways. Handb Exp Pharmacol. 2013;218:31-58.

Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1):167-9.

Charalampopoulos A, Lewis R, Hickey P, Durrington C, Elliot C, Condliffe R, et al. Pathophysiology and diagnosis of pulmonary hypertension due to left heart disease. Front Med. 2018;5:174.

Zanjani KS. Platelets in pulmonary hypertension: a causative role or a simple association? Iran J Pediatr. 2012;22(2):145-57.

Nguyen QL, Corey C, White P, Annie Watson 3, Mark T Gladwin 1 2, Marc A Simon, et al. Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity. JCI Insight. 2017;2(5):91415.

Varol E, Uysal BA, Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension. Clin Appl Thromb Hemost. 2011;17(6):171-4.

Yaoita N, Shirakawa R, Fukumoto Y, Sugimura K, Miyata S, Miura Y, et al. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014;34(11):2486-94.

Zheng YG, Yang T, Xiong CM, He JG, Liu ZH, Gu Q, et al. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension. Heart Lung Circ. 2015;24(6):566-72.

Kinare SG, Deshpande J. Primary pulmonary hypertension in India (autopsy study of 26 cases). Indian Heart J. 1987;39(6):9-16.

Negi PC, Marwaha R, Asotra S, Kandoria A, Ganju N, Sharma R, et al. Prevalence of high altitude pulmonary hypertension among the natives of Spiti Valley-a high altitude region in Himachal Pradesh, India. High Alt Med Biol. 2014;15(4):504-10.

Weaver H, Tulloh R. Thrombocytopenia in pulmonary hypertension, does it predict survival? Eur Heart J. 2013;34(1):318-22.

Güvenc TS, Erer HB, Ilhan S, Zeren G, Ilhan E, Karakuş G, et al. Comparison of mean platelet volume values among different causes of pulmonary hypertension. Cardiol J. 2012;19(2):180-7.